Screener
Insulet PODD U.S.Omnipod — Total Revenue
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Insulet in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The source filing: Insulet’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001145197-26-000169
| (in millions) | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| U.S. | $544.1 | $453.2 | $1,059.7 | $854.9 |
| International | 251.8 | 185.8 | 494.6 | 338.1 |
| Total Omnipod products | 795.9 | 639.0 | 1,554.3 | 1,193.0 |
| Drug Delivery | 5.8 | 10.2 | 9.1 | 25.1 |
| Total revenue | $801.7 | $649.1 | $1,563.4 | $1,218.1 |
Item 1. Condensed Consolidated Financial Statements (Unaudited)
FAQ
- What is Insulet's u.s.omnipod — total revenue?
- Insulet (PODD) reported u.s.omnipod — total revenue of $544.1M in Q2 2026.
- How has Insulet's u.s.omnipod — total revenue changed year-over-year?
- Insulet's u.s.omnipod — total revenue increased by 20.1% year-over-year, from $453.2M to $544.1M.
- What is the long-term trend for Insulet's u.s.omnipod — total revenue?
- Over 4 years (2021 to 2025), Insulet's u.s.omnipod — total revenue has grown at a 31.0% compound annual growth rate (CAGR), from $651.5M to $1.92B.
- What does u.s.omnipod — total revenue mean?
- This metric represents the total gross sales generated from the sale of insulin delivery systems and associated consumables within the domestic market. It reflects the company's ability to capture market share and drive adoption of its flagship wearable medical device technology among insulin-dependent patients. Growth in this segment is a primary indicator of the company's domestic commercial success and the scalability of its direct-to-consumer and pharmacy-channel distribution models.
Ask your AI about Insulet's u.s.omnipod — total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude